2021 Annual Meeting | TRANSCENDS Program
Program Materials Program Evaluations
| 07:00 AM - 05:00 PM EDT | Abstract |
099 - Comparison of SATURN, a free, electronic, self-administered cognitive screening test to the Montreal Cognitive Assessment in Latinos in a northern California agricultural region
Gabriel M. Moreno, MD |
| 07:00 AM - 05:00 PM EDT | Abstract |
271 - Outcomes Associated with Delay in Nutrition in Patients with Aneurysmal Subarachnoid Hemorrhage
Tachira Tavarez, MD |
| 07:00 AM - 05:00 PM EDT | Abstract |
272 - A spectrum of Scalp EEG Correlates of Hippocampal Spikes
Maria J. Bruzzone, MD |
| 07:00 AM - 05:00 PM EDT | Abstract |
273 - Expanding the phenotypic spectrum of diabetic striatopathy: a case series
Karlo J. Lizarraga, MD, MS, FAAN |
| 07:00 AM - 05:00 PM EDT | Abstract |
274 - Language Discordance Between Patient and Physician on Time-to-Thrombolysis Recommendations via Telestroke
Alejandro Vargas, MD, MS |
| Tachira Tavarez, MD | Dr. Tavarez has nothing to disclose. |
| Gabriel M. Moreno, MD | Dr. Moreno has nothing to disclose. |
| Maria J. Bruzzone, MD | Dr. Bruzzone has nothing to disclose. |
| Karlo J. Lizarraga, MD, MS, FAAN | Dr. Lizarraga has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for FHC. The institution of Dr. Lizarraga has received research support from Acadia. The institution of Dr. Lizarraga has received research support from Roche. The institution of Dr. Lizarraga has received research support from NIH/NINDS. The institution of Dr. Lizarraga has received research support from Takeda. Dr. Lizarraga has received personal compensation in the range of $0-$499 for serving as a Speaker with AAN Institute. Dr. Lizarraga has a non-compensated relationship as a Editorial Board Member with AAN (Brain & Life en Español) that is relevant to AAN interests or activities. |
| Alejandro Vargas, MD, MS | Dr. Vargas has nothing to disclose. |